Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Clinical and Laboratory Characteristics of Polycythemia Vera

NCT06134102

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo, Apulia, Italy
  • Grande Ospedale Metropolitano "Bianchi Melacrino Morelli" Reggio Calabria, Calabria, Italy
  • IRCCS Policlinico Sant'Orsola Bologna, Emilia-Romagna, Italy
  • Università degli studi di Ferrara - Nuovo Polo Ospedaliero di Cona - A.O.U. Arcispedale S. Anna Ferrara, Emilia-Romagna, Italy
View all 22 locations
View Trial Details
Completed

A Prospective, Non-interventional Study of JAKAVI® (Ruxolitinib) Treatment in Patients With Polycythemia Vera

NCT05853445

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Novartis Investigative Site Heidenheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Mannheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Reutlingen, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Winnenden, Baden-Wurttemberg, Germany
View all 99 locations
View Trial Details
Completed

Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers

NCT01597219

Conditions
Acquired Bone Marrow Failure Syndromes, Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, +33 more
Locations
  • Birmingham Heartlands Birmingham, United Kingdom
  • Bristol Royal Infirmary Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • Beatson Hospital Glasgow, United Kingdom
View Trial Details
Completed

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

NCT03959241

Conditions
Acute Leukemia, Anemia, Anemia, Refractory, +22 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
View all 39 locations
View Trial Details
Completed

Special Drug Use-results Surveillance of Scemblix Tablets

NCT05421091

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Anjo, Aichi-ken, Japan
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Kasugai, Aichi-ken, Japan
  • Novartis Investigative Site Komaki, Aichi-ken, Japan
View all 278 locations
View Trial Details
Completed

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

NCT02081378

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +13 more
Locations
  • Dana Farber Cancer Institute Hematology / Oncology Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering New York, United States
  • Oregon Health Sciences University SC-6 Portland, Oregon, United States
View all 18 locations
View Trial Details
Completed

PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit

NCT04767802

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Hospital Sultanah Aminah Johor Bahru, Johor, Malaysia
  • Hospital Raja Perempuan Zainab Kota Bharu, Kelantan, Malaysia
  • Hospital Raja Permaisuki Bainun Ipoh, Perak, Malaysia
  • Hospital Umum Sarawak Kuching, Sarawak, Malaysia
View Trial Details

Related conditions